Hugh Griffith
Fundador en NUCANA PLC .
Fortuna: 328 907 $ al 31/03/2024
Cargos activos de Hugh Griffith
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
NUCANA PLC | Director/Miembro de la Junta | 20/03/2008 | - |
Director Ejecutivo | 20/03/2008 | - | |
Fundador | 28/01/1997 | - | |
EdixoMed Ltd.
EdixoMed Ltd. BiotechnologyHealth Technology Part of Mativ Holdings, Inc., EdixoMed Ltd. engages in research and development of biotechnology. The company is based in Edinburgh, UK. The British company was founded by Hugh Stephen Griffith. | Director/Miembro de la Junta | 01/01/2009 | - |
Fundador | 01/01/2009 | - | |
MedAnnex Ltd.
MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom. | Director/Miembro de la Junta | 14/06/2010 | - |
Fundador | 01/01/2009 | - |
Historial de carrera de Hugh Griffith
Antiguos cargos conocidos de Hugh Griffith.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Director de Operaciones | 01/10/2002 | 01/01/2007 |
Ernco 200 LTD
Ernco 200 LTD Pharmaceuticals: MajorHealth Technology Ernco 200 LTD manufactured pharmaceutical Foscan for cancer treatment, specializes in photodynamic therapy. The company was headquartered in Stirling, the United Kingdom. | Corporate Officer/Principal | 01/01/2002 | 01/09/2002 |
ABBOTT LABORATORIES | Corporate Officer/Principal | 01/10/1995 | 01/12/2001 |
Warner Lambert (UK) Ltd.
Warner Lambert (UK) Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Warner Lambert (UK) Ltd. is a manufacturer and wholesaler of pharmaceuticals and over the counter medicines. The company is based in Eastleigh, UK. | Corporate Officer/Principal | 01/04/1992 | 01/10/1995 |
Thirty Holdings Ltd.
Thirty Holdings Ltd. Packaged SoftwareTechnology Services Thirty Holdings Ltd. operates as a holding British company whose subsidiary develops an anti-infective nitric oxide technology platform for the healthcare sector. The company is based in London, UK. The company was founded in 2018 by Christopher Barry Wood. | Director/Miembro de la Junta | - | - |
Alida Capital International Ltd.
Alida Capital International Ltd. Investment ManagersFinance Alida Capital International Ltd. Provides capital and practical assistance for emerging biopharmaceutical companies. The company was founded by Hugh S. Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom. | Director/Miembro de la Junta | 01/01/2009 | - |
Director Ejecutivo | 01/01/2009 | - | |
Fundador | 01/01/2009 | - | |
░░░░░░░░░░░ ░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formación de Hugh Griffith.
The University of Stirling | Undergraduate Degree |
Cardiff Business School | Masters Business Admin |
Estadísticas
Internacional
Reino Unido | 11 |
Estados Unidos | 3 |
Operativa
Director/Board Member | 5 |
Corporate Officer/Principal | 4 |
Founder | 4 |
Sectorial
Health Technology | 7 |
Consumer Services | 3 |
Health Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ABBOTT LABORATORIES | Health Technology |
NUCANA PLC | Health Technology |
Empresas privadas | 8 |
---|---|
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Health Services |
Parke-Davis & Co. Ltd.
Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Health Technology |
Ernco 200 LTD
Ernco 200 LTD Pharmaceuticals: MajorHealth Technology Ernco 200 LTD manufactured pharmaceutical Foscan for cancer treatment, specializes in photodynamic therapy. The company was headquartered in Stirling, the United Kingdom. | Health Technology |
Warner Lambert (UK) Ltd.
Warner Lambert (UK) Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Warner Lambert (UK) Ltd. is a manufacturer and wholesaler of pharmaceuticals and over the counter medicines. The company is based in Eastleigh, UK. | Health Technology |
Alida Capital International Ltd.
Alida Capital International Ltd. Investment ManagersFinance Alida Capital International Ltd. Provides capital and practical assistance for emerging biopharmaceutical companies. The company was founded by Hugh S. Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom. | Finance |
EdixoMed Ltd.
EdixoMed Ltd. BiotechnologyHealth Technology Part of Mativ Holdings, Inc., EdixoMed Ltd. engages in research and development of biotechnology. The company is based in Edinburgh, UK. The British company was founded by Hugh Stephen Griffith. | Health Technology |
MedAnnex Ltd.
MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom. | Commercial Services |
Thirty Holdings Ltd.
Thirty Holdings Ltd. Packaged SoftwareTechnology Services Thirty Holdings Ltd. operates as a holding British company whose subsidiary develops an anti-infective nitric oxide technology platform for the healthcare sector. The company is based in London, UK. The company was founded in 2018 by Christopher Barry Wood. | Technology Services |
- Bolsa de valores
- Insiders
- Hugh Griffith
- Experiencia